Steve Kean will transition from leading Kinder Morgan to assuming the role of president and CEO of the Greater Houston Partnership later this year. Photo courtesy of the GHP

A longtime energy executive has been named the next president and CEO of the Greater Houston Partnership. He'll take on the new role this fall.

The GHP named Steve Kean, who currently serves as the CEO of Kinder Morgan Inc., to the position. He's expected to transition from CEO to board of directors member at Kinder Morgan on August 1. Kean will then assume his new position at GHP no later than Dec. 1.

Dr. Marc L. Boom, GHP board chair and president and CEO of Houston Methodist, made the announcement at a press conference June 21.

“Steve brings incredible business acumen and leadership skills to the organization," Boom says in a statement. "Coupled with an extraordinary passion for Houston, he will build on the Partnership’s momentum to continue to advance greater Houston as a region of extraordinary growth and opportunity.”

The GHP's outgoing president and CEO, Bob Harvey, announced his retirement earlier this year, and will remain in his position until Kean is onboarded. Kean was selected via a search committee established by 2022 board chair, Thad Hill. The committee was chaired by Marc Watts and included Boom, Thad Hill, Paul Hobby, Gina Luna, Eric Mullins, Armando Perez, and Ruth Simmons. The process, which looked at over 70 highly-qualified Houston leaders, also included the services of Spencer Stuart to manage the search.

“This last decade has been a dynamic time for Houston and the Partnership," Harvey says in a statement. "As a life-long Houstonian, it has been an honor to focus my efforts on supporting Houston’s continued growth and working with the business community to create opportunities for all Houstonians. This is an exciting time for Houston. I am very pleased that Steve is enthusiastic about leading the Partnership, and I look forward to the organization’s continued success under his leadership.”

With decades in the energy industry, Kean joined Kinder Morgan in 2002 and has served as COO, president of Natural Gas Pipelines, and president of Kinder Morgan Inc. before rising to CEO. He received a bachelor's degree from Iowa State University and his law degree from the University of Iowa.

“I’m grateful for the opportunity to serve our region in this role," he says. "I look forward to building on what Bob, the Board, members, and staff of the Partnership have accomplished. I know first-hand the opportunities that a vibrant business sector can create for people and communities. I look forward to expanding those opportunities further.”

Bob Harvey has announced his retirement plans. Photo courtesy of GHP

Greater Houston Partnership leader to retire, executive search committee forms to find new CEO

transition plans

Bob Harvey, who has been at the helm as the Greater Houston Partnership for over a decade has announced his retirement plans.

In an announcement today, the GHP revealed that Harvey, the president and CEO of the organization since 2012, plans to retire at the end of the year.

“This last decade has been a dynamic time for Houston and the Partnership. As a life-long Houstonian, it is a true honor to wake up each day focused on supporting Houston’s growth and working with the business community to create opportunities for all Houstonians,” says Harvey in a news release. “The commitment of business leaders to the success of this region is inspiring, and I look forward to continuing to lead the Partnership over the next year as we move Houston forward.”

Thad Hill, the current board chair of GHP and president and CEO of Calpine Corporation, has created an executive search committee made up of Partnership board members and chaired by Marc Watts, the 2018 Partnership board chair and president of The Friedkin Group. According to the release, the search will be national but the new CEO will be expected to "have some working familiarity with Houston and its business community." Current staff members will also be considered.

“I want to thank Bob for his tremendous leadership over the last decade as we’ve made great strides as an organization and as a region,” Hill says in the release. “I am grateful that Bob will continue to advance the organization over the coming months as we begin the process to find his successor. Under Bob’s leadership, the Partnership plays an essential role in the inclusive growth and prosperity of our great community, and I am confident his successor will expand on that legacy.”

The GHP is an economic development organization that serves the 12-county region encompassing Houston. It also acts as the business community’s advocate within policy across the local, state, and federal levels.

Under Harvey, the GHP has rolled out several initiatives, including workforce development program UpSkill Houston, the Houston Energy Transition Initiative, and diversity, equity, and inclusion program One Houston Together.

“The Partnership is an outstanding organization with strong board and staff leadership, impeccable financials, and a mission-oriented bias for action to make Houston a better place to live, work and build a business,” Hill says in the release. “The next leader of the Partnership is set-up to succeed, and I look forward to the process to identifying this person who will continue the organization’s momentum forward.”

The Greater Houston Partnership announced a new mentorship-focused initiative in the region. Photo via Houston.org

Houston organizations team up to provide mentorship, address gaps in the workforce

future of Hou

A mix of corporate and university organizations have teamed up with the Greater Houston Partnership for a new program that enables mentorship for local college students.

The GHP announced PartnerUp Houston, a new regional mentorship initiative, this week. Ten companies — including Calpine, Boston Consulting Group, and HP — have agreed to provide professional mentors and a handful of universities will offer the mentorship opportunity to students. The local universities that are signed on include Houston Christian University, Rice University, Sam Houston State University, University of Houston, and University of St. Thomas.

“Since 2017, the Partnership has facilitated collaboration between higher education leaders and the business community to strengthen the region’s talent pipeline and ensure more opportunity for Houstonians,” says Partnership Chair Thad Hill, who serves as president and CEO of Calpine, in a news release. “We believe a robust, regional mentorship program like PartnerUp will help accelerate career outcomes for students and help Houston area employers identify and cultivate great talent.”

The program is still seeking individuals and corporate partners for mentors. Those interested have until January 20 to opt in and can head online to learn more.

The program is a collaboration between the GHP and Mentor Collective, which has organized more than 250,000 successful mentorship matches since its founding in 2016.

“The United States increasingly lags behind the developed world in economic mobility," says Jackson Boyar, co-founder and CEO of Mentor Collective, in the release. "Proactively bridging these equity and skills gaps requires local employers and post-secondary institutions to collaborate on initiatives that allow students to acquire professional experiences and skills.”

“Institutions enrolling and graduating a diverse class with strong employment outcomes are those implementing holistic student support, including career mentorship," he continues. "Mentor Collective is proud to play a role in the PartnerUp Houston initiative and offer the technology needed to scale high-impact practices that drive student and economic success.”

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”

Houston startup raises $6M to scale home-based healthcare platform

fresh funding

As healthcare systems race to expand care beyond hospitals and into the home, investors are placing bigger bets on the infrastructure needed to make that shift possible.

This month, Rosarium Health announced it has raised $6 million in seed funding led by Kalos Ventures, with participation from ResilienceVC, Rock Health Capital, Symphonic Capital, Black Tech Nations Ventures and others.

The investment will help the Houston-based startup continue to build its platform, which features a national network of 800-plus clinicians and 3,000-plus contractors to coordinate home accessibility upgrades and modifications for seniors and people living with disabilities.

For founder and CEO Cameron Carter, the company’s mission grew out of firsthand caregiving experiences.

“From my own personal caregiving experiences, I realized that the benefits exist on paper, but not in reality,” Carter said in a news release. “Families are being left to figure out the paperwork and installations all on their own, which shouldn’t be how this works.”

While Medicare Advantage and Medicaid plans have expanded coverage for home-based services and accessibility modifications, the logistics behind delivering those services often remain fragmented.

Rosarium’s platform coordinates the entire process, from clinical assessments and referrals to contractor management, documentation, reimbursement and installation.

“A clinician can document that a home isn’t safe and a plan can approve a benefit, but there’s no one that’s responsible for making sure the work actually gets done,” Carter says. “We built the missing piece.”

The company was founded in 2021 as Rose Health and was a 2023 participant in the Texas Medical Center’s Accelerator for HealthTech program. It has scaled quickly, building a network of more than 800 clinicians and 3,000 contractors across 34 states.

Rosarium is currently in-network for 1.2 million Medicare and Medicaid lives, with projected coverage expected to reach nearly 4 million by the end of the year, according to the release.

“We’re excited to back Cameron because he and the team at Rosarium are building the infrastructure healthcare needs right now to make the home a safe and comfortable place of care,” Kate Ballinger, investor at Kalos Ventures, added in the release.

As part of the recent investment, Ballinger will join Rosarium’s board of directors.

With eyes on the future, Rosarium plans to grow its partnerships with Medicaid and Medicare Advantage plans, including CalViva and Community Health Plan of Imperial Valley, strengthening its presence in California while expanding access to underserved communities.

Additionally, Carter predicts that home-based healthcare will be part of a broader transformation happening across the industry.

“There’s a growing recognition that health outcomes are shaped by what happens in the home,” he said in the release. “The future of healthcare isn’t just treating people after something goes wrong. It’s creating environments that help prevent those problems in the first place.”